Neurological disorders in rural Africa - a systematic approach by Winkler, S et al.
African Journal of Neurological Sciences 2008 - Vol. 27, No 2
NEUROEPIDEMIOLOGY / NEUROEPIDEMIOLOGIE
NEUROLOGICAL DISORDERS IN RURAL AFRICA - A SYSTEMATIC APPROACH
TROUBLES NEUROLOGIQUES EN AFRIQUE RURALE - UNE APPROCHE SYSTEMATIQUE
 WINKLER Andrea Sylvia 1 
 MOSSER Philipp 2 
 MATUJA William 3 
 SCHMUTZHARD Erich 2 
1. Interdisciplinary Centre for Palliative Medicine and Department of Neurology, Ludwig-Maximilians-
University, Munich, Germany 
2. Department of Neurology, University Hospital, Innsbruck, Austria 
3. Department of Neurology, Muhimbili National Hospital, Dar es Salaam, Tanzania 
E-Mail Contact - WINKLER Andrea Sylvia : drawinkler (at) yahoo (dot) com.au   
Key words: classification; epidemiology ; hospital prevalence; neurological disorders; resource poor setting; 
rural Africa; Tanzania; 




Les troubles neurologiques sont fréquents en Afrique sub-saharienne. Toutefois, à ce jour des études 
épidémiologiques sont rares. Les objectifs de notre étude étaient d’évaluer la prévalence des troubles 
neurologiques en milieu hospitalier dans un cadre rural Africain et de décrire la présentation de ces 
maladies en utilisant une approche systématique.
Méthodes 
L’étude a été menée à l’Hôpital Haydom luthérienne dans le nord de la Tanzanie, région de Manyara. Dans 
une étude prospective sur une période de huit mois, tous les patients admis à l’hôpital ont été évalués par 
un neurologue (ASW).
Résultats 
Sur 8676 admissions 740 patients (8.5%) ont reçu un diagnostic neurologique. Les troubles neurologiques 
les plus fréquents ont été les convulsions (26.6%) et les maladies infectieuses (18.1%). La mortalité globale 
de maladie neurologique a été de 21%. Des cas ont été regroupés en fonction de la certitude du diagnostic. 
Nous proposons trois grandes catégories de troubles neurologiques (groupe 1 = pas d’incertitudes 
diagnostiques; groupe 2 = incertitudes diagnostiques mineures; groupe 3 = incertitudes diagnostiques 
majeures) avec des implications en ce qui concerne la thérapie et le pronostic.
Conclusions 
Les données ci-dessus soulignent que les maladies neurologiques contribuent fortement à la morbidité et la 
mortalité dans un hôpital rural en Afrique. Sur la base de présentations des troubles neurologiques 
observés nous proposons une approche systématique.
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SUMMARY
Background/Objectives 
Empirical knowledge suggests that neurological disorders are common in sub-Saharan Africa. However, to 
date prevalence studies are scarce. The aims of our study were to assess the hospital-based prevalence of 
neurological disorders in a rural African setting and to describe the pattern of disease by using a systematic 
approach.
Methods 
The study was conducted at the Haydom Lutheran Hospital in northern Tanzania, Manyara region. Over a 
period of eight months all patients admitted to hospital were seen prospectively in consecutive order by a 
neurologist (ASW).
Results 
Out of 8676 admissions 740 patients (8.5%) were given a neurological diagnosis. The most frequent 
neurological disorders were seizures (26.6%) and infectious diseases (18.1%). The overall mortality of 
neurological disease was 21%. Cases were grouped according to diagnostic certainty. We suggest three 
major categories for neurological disorders (group 1 = no diagnostic uncertainties; group 2 = minor 
diagnostic uncertainties; group 3 = major diagnostic uncertainties) with implications regarding therapy and 
prognosis.
Conclusions 
The above data emphasizes that neurological disease contributes substantially to morbidity and mortality in 
a rural African hospital. Based on the observed pattern of neurological disorders we suggest a systematic 
approach
INTRODUCTION
Not much is known about the epidemiology, natural history, clinical pattern, aetiologies and treatment status 
of neurological disorders in developing countries. A study carried out in Mnero, southern Tanzania, showed 
that 10% of all inpatients of a rural hospital suffered from neurological diseases and a study conducted in a 
tertiary hospital in Dar es Salaam demonstrated that 13% of all newly admitted patients had neurological 
disorders [12, 18]. The most comprehensive work on neurological diseases in tropical Africa comes from 
Ibadan, a university hospital in Nigeria [13]. It describes the pattern of neurological diseases in a hospital 
population of 9600 patients over a period of 12 years. The most frequent neurological disorders were found to 
be infections of the nervous system with a prevalence of 8.3/1000 in the hospital population. Tetanus 
accounted for 20% of all neurological diseases and was by far the commonest neurological disorder, followed 
closely by meningitis with a prevalence of 6/1000. Epilepsy was the third commonest disease of the nervous 
system. The prevalence in the hospital population was 3.2/1000 [13]. Recent data from a Zambian study that 
investigated the pattern of neurological illnesses in a rural hospital confirmed the distribution of neurological 
diseases found by Osuntokun in Nigeria. The Zambian study, however, showed seizures of different origin to 
be the most frequent neurological disorder, followed by neuropathies, with infection of the central nervous 
system being on position number three [2].
The emphasis of the neurological disease spectrum seems to be on seizure disorders and infectious 
diseases of the central nervous system. Although the above studies clearly point out the areas where the 
burden of neurological disease lies, not much is being said about patients who present with clear neurological 
symptoms and/or signs, but cannot be diagnosed with certainty due to lack of appropriate tools. These cases 
are, according to the authors’ experiences, as important as the clear-cut neurological cases when defining 
the prevalence of neurological disorders in developing countries. In this paper, we describe the pattern of 
neurological disease and suggest a systematic approach for neurological disorders, including those with 
diagnostic uncertainties, suitable for most mid size rural African hospitals.
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METHODS
The hospital-based study was conducted at the Haydom Lutheran Hospital in northern Tanzania, Manyara 
region. Of 8676 admissions all patients with neurological signs and/or symptoms were seen prospectively in 
consecutive order by a specialist neurologist (ASW) over a period of eight months in 2003. This was also 
extended to referral cases, i.e. patients who developed neurological signs and/or symptoms during their 
admission in the wards, which were not necessarily present at the time of admission to the hospital. 
Neurological disorders also included confusion and/or impairment of consciousness. Patients were examined 
on admission and then followed up at regular intervals. All patients recruited during the study were put into 
clearly defined “diagnostic groups” (see below). Each patient was allocated to a “diagnostic group” only once. 
If the patient presented with different neurological disorders at the same time, he was classified according to 
the predominant neurological sign/symptom. If the patient was re-admitted because of the same neurological 
problem, he was recorded only once. If the patient was re-admitted because of a new neurological disorder, 
he was treated as if not having been admitted before.
Basic laboratory examinations, microbiology, cerebrospinal fluid (CSF) analysis and conventional x-ray were 
available, but there was no access to either sophisticated neuroimaging (computed tomography, magnetic 
resonance imaging, angiography) or proper electrophysiology. Also, HIV testing was not available as a 
routine test at the time of the study. Demographic information, medical history, results of physical 
examination on admission and at regular intervals during the period of admission, laboratory results and 
clinical outcome were documented in the medical records of all patients by the same doctor (ASW). Daily 
ward nursing notes on established patients were reviewed for identification of anyone who developed a 
neurological problem after initial hospitalization. The notes of eleven patients were missing, their diagnoses 
were however known. The approach to grouping the observed neurological disorders was different from the 
usual classification of neurological disorders in northern/western countries where diagnostic tools are at 
hand. Based on the experience gained during the study, we opted for a pragmatic way and chose a three-
pronged approach. Group 1: disorders without diagnostic uncertainties based on a) medical history and 
clinical examination only (e.g. epilepsy, febrile seizures, rabies) or b) medical history and clinical examination 
together with confirmatory laboratory tests (e.g. cerebral malaria, meningitis); Group 2: syndromes that are 
known, but which remain with minor diagnostic uncertainties. Presumptive diagnoses may be reached, but for 
confirmation of diagnosis, subcategorisation and appropriate treatment more sophisticated tests would be 
necessary such L-dopa trial, electrophysiology, imaging etc. Group 3: syndromes that are unknown, thus 
representing major diagnostic uncertainties. They can however be described and grouped accordingly. 
Additional laboratory tests are not helpful (assuming that HIV testing is not available). Cases within this group 
are similar in terms of combination of their neurological signs and symptoms and show a similar spectrum 
regarding therapy and prognosis; the causative mechanisms remain unknown.
Diagnostic Criteria
Group 1 (no diagnostic uncertainties)
Diagnoses within this group (Table 2) were derived from current guidelines and standard textbooks of 
neurology, and thus will not be mentioned separately [1, 2, 5-7, 12-14, 16-22].
Group 2 (minor diagnostic uncertainties; presented in the order as they appear in Table 3)
Myelopathies, radiculopathies, plexopathies and polyneuropathies 
In this group, patients were classified according to the site of the lesion as determined by neurological 
examination. Other results, clinical or from x-ray, were also considered. Four syndromes, i.e. myelopathy, 
radiculopathy, plexopathy and polyneuropathy or any combination thereof, were grouped together. If the 
cause was known, a “true diagnosis” would be established and the case put into group 1.
Seizures other than epilepsy and febrile convulsions 
Here patients with seizures as a presenting complaint who did not meet the criteria for epilepsy or febrile 
convulsions were summarized. If the seizure(s) was (were) associated with intracranial infection or lesions, 
the patients were classified into the respective groups.
Non-infectious encephalopathies 
To this group patients with acute or chronic non-infectious encephalopathy due to presumptive mechanisms 
were assigned. If the reason for the encephalopathy was unknown, patients were classified according to the 
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prominent neurological signs(s) into “acute confusional state unclassified”, “impairment of consciousness 
unclassified” or “obscure encephalopathy” (see group 3).
Cerebrovascular accident (CVA) 
This included ischaemic cerebral disease as well as intracerebral haemorrhage. Without appropriate imaging 
it is difficult to differentiate CVA from cerebral masses. In the former, signs of infection are absent. The onset 
of neurology is acute and if there is progression, it usually develops fast. This is contrary to most space-
occupying lesions which have a rather protracted course of disease.
Degenerative diseases 
This group was divided into three subgroups: 1) extrapyramidal disorders, 2) cerebellar syndromes and 3) 
motor neuron disease [5, 14].
Dementia and mental retardation 
The most prominent feature of this group was impairment of cognition unexplained by physical or 
neurological illness. This was either due to intellectual decline (dementia) or non-achievement of full mental 
capacities (mental retardation) [5, 14].
Paroxysmal events 
Patients who qualified for this group either experienced syncopes, vertigo or neuralgias, or suffered from 
migraine [5, 14].
Space-occupying lesions 
This is a difficult diagnosis in the absence of imaging. Patients with progressive focal neurological signs 
associated with signs/symptoms of increased intracranial pressure such as headache, nausea/vomiting, 
blurred vision, dizziness and ataxia etc, were allocated to this group. Progression usually is slow with some 
exceptions such as e.g. intracerebral abscesses or cerebral toxoplasmosis where a more rapid course of 
disease can be expected. In most of these cases, signs of infection/immunosuppression or neoplasma are 
present. Patients with focal neurological signs in the context of meningoencephalitis, i.e. the presence of 
meningism associated with focal neurology, were excluded, as were patients who developed neurological 
signs following a CVA (see above).
Myopathies 
This group included patients suffering from muscle weakness and/or pain without any sensory impairment in 
the absence of signs/symptoms of peripheral neuropathies, radiculopathies or motor neuron disease, 
amongst others, that may account for their muscle weakness [5, 14]. Diagnoses were established clinically as 
we did not have access to electromyography.
Group 3 (major diagnostic uncertainties)
According to the circumstances in a rural African hospital we were left with a group of patients who did not fit 
any of the diagnostic criteria mentioned above. In syndromic terms, we were able to group them into three 
different categories.
Acute confusional state (ACS) unclassified 
Patients grouped here had to fulfil the following diagnostic requirements: 1) the confusion is acute but 
reversible (unless systemic illness led to death) without major impairment of consciousness; 2) there is 
absence of persistent neurological signs/symptoms. If minor focal neurological signs/symptoms are present 
they should be reversible as the confusion tapers off. Signs/symptoms of systemic illness may be present; 3) 
the confusion is not caused by a “non-infectious encephalopathy” (these patients are summarized in group 2).
Impairment of consciousness (IOC) unclassified 
Patients who qualified for this group presented with IOC alone without major neurological signs. The same 
criteria as for “acute confusional state unclassified“ are applied.
Obscure encephalopathies 
Patients summarized in this group had to fulfil the following diagnostic criteria: 1) non-focal neurological signs 
are predominating; 2) there may be an association with acute confusion, impairment of consciousness, or 
dementia, however, these neurological signs are not to prevail; 3) even after careful evaluation no reason for 
the encephalopathy is found, thus it is labelled obscure.
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Ethical clearance and data analysis
Ethical approval was obtained from the National Institute of Medical Research (NIMR) and the study was 
cleared by the Tanzania Commission for Science and Technology (COSTECH). Free and informed consent 
from the patients or, in case of children, their respective parents was also obtained. The data of all patients 
was put into a data bank using Microsoft Excel. The same program was used for calculations (e.g. mean age 
with standard deviation).
RESULTS
Hospital-based prevalence of neurological disorders
Seven hundred and forty patients with neurological disorders were admitted within approximately eight 
months. Not included were patients with head injuries presenting without neurological signs/symptoms, those 
with non-neurological backache and those with psychiatric disorders. In the same period of time, a total of 
8676 patients were admitted. Thus the hospital-based prevalence of patients with neurological diseases was 
85.29/1000 admissions. Demographic details are given in Table 1.
Classification of neurological disorders
The leading diagnostic group was group 1 (n=340) with disorders that were either diagnosed on clinical 
grounds alone or needed simple but widely available tests to confirm diagnosis. This was closely followed by 
group 2 (n=318). Although syndromic description of cases was possible, a satisfactory diagnosis in most 
cases could not be reached. The available tools were not appropriate to achieve diagnostic certainty. Eighty-
two patients were allocated to group 3 consisting of syndromic cases which, contrary to group 2, did not fit 
any of the established neurological criteria. Cases were grouped according to their clinical presentation.
Group 1 (no diagnostic uncertainties)
As to the first group, the distribution of diagnoses is listed in Table 2. The two leading causes of neurological 
disease in that group were febrile seizures and meningitis. Most febrile convulsions were complex in nature 
(64%) with recurrent seizures, prolonged convulsion or ensuing neurological sequelae. In most meningitis 
cases, the causing organism remained unclear. Twenty-six percent were caused by Neisseria meningitidis, 
19% by Streptococcus pneumoniae and 13% by Haemophilus influenzae. The latter proved to be multi-
resistant. For the other disorders see Table 2.
Group 2 (minor diagnostic uncertainties)
Three hundred and eighteen patients could be allocated to group 2. Leading were lesions of the spinal cord 
and/or along sites of the originating nerve fibres resulting in myelopathies (33%), radiculopathies (18%), 
plexopathies (7%) and cauda equina compressions (5%). Polyneuropathies (PNP) made up for 31% and 
were caused by diabetes, alcohol as well as Isoniazid. Guillain-Barré syndrome (2%), a 
polyradiculoneuropathy, was also classified in that group. In 5% syndromes were combined.
Next came head injuries with neurological impairment ranging from temporary loss of consciousness to deep 
coma. Without cerebral computed tomography a definite diagnosis regarding the origin of the neurological 
signs could not be reached. Epileptic seizures which were neither classified as epilepsy nor as febrile 
convulsion made up for 15.4% of the cases of group 2. In most cases, causes remained unknown. The group 
of seizures was followed by the group of the non-infectious encephalopathies which consisted of a potpourri 
of presumptive causes as opposed to the obscure encephalopathies. The origin however was non-infectious 
and might be due to toxic agents (35%), metabolic (28%), hypoxic (14%) and nutritional (7%) disturbances. 
16% remained undetermined.
Then came CVA and degenerative diseases with 10.4% and 6.6%, respectively. The latter was divided into 
movement disorders and motorneuron disease. Of the 21 patients eight had parkinsonism, three chorea 
minor, three isolated tremor syndromes, two isolated cerebellar syndromes and two patients had 
motorneuron disease. Single patients presented with generalised chorea and generalised dystonia due to 
unknown cause as well as a spasmodic torticollis. Further details of group 2 are given in Table 3. Whereas 
the origin of the dementia cases (58%) remained cryptogenic, mental retardation (42%) was mainly caused 
by intrauterine or intrapartum/postpartum complications. Presumptive causes for paroxysmal events were 
syncope (53%), neuralgias (35%), migraine (6%) and Ménière’s disease (6%). The space-occupying lesions 
with 4.1% of group 2 were most likely due to brain metastases in two cases, HIV related toxoplasmosis in two 
cases and a bone eroding soft tissue tumor in one case. The origin of the other cases (n=8) remained 
unclear. 57% of the myopathies were due to tropical pyomyositis. The remaining three patients had muscle 
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wasting without obvious cause.
Group 3 (major diagnostic uncertainties)
Despite allowing for syndromic grouping in group 2, 11% of the neurological cases could not be allocated to 
any of the syndromes, indicating the dilemma of resource limited countries (Table 4). The criteria of group 3 
were developed according to our observation that some of the cases seem to have a consistent pattern (see 
diagnostic criteria above). A subgroup of patients is middle aged presenting with either acute confusion or 
impaired consciousness. Neurological signs, if present, are not in the forefront. Lumbar puncture was 
performed in 16 of the 66 patients and revealed normal findings. On clinical grounds and with simple 
laboratory tests symptoms could not be explained, otherwise cases would have been put into the respective 
diagnostic groups. Syndromes were termed “acute confusional state unclassified” or “impairment of 
consciousness unclassified” (Table 4 and 5). The mortality in these patients was high with 17.5% and 42%, 
respectively, the hospital stay however seemed to be short (Table 5).
Another group is that of patients with mainly progressive encephalopathies, the reason of which remains 
unclear, thus the descriptive term “obscure” was added. In that group, generalised neurological signs such as 
increased muscle tone and symmetrically increased reflexes are predominating, focal neurological signs are 
however absent. Frontal release signs are often observed. Confusion and impairment of consciousness can 
be present, but are not prevailing in the beginning. Lumbar puncture was performed in 14 of the 16 patients 
and revealed normal findings. Simple laboratory tests were within normal range. These patients tended to be 
hospitalised for a long period, the expenses for most families were exorbitant and the mortality was high 
(Table 5).
DISCUSSION
This paper mainly aims at the overall description of neurological disease in a rural African Hospital. Thus 
single neurological disorders will not be discussed. They are however described in more detail in the result 
section above and are summarized in the tables.
Is neurology relevant in developing countries? Our own experience and that of other colleagues suggest that 
neurological disorders are underestimated and often overlooked in developing countries. Many neurological 
diseases are of acute onset and their course may be rapidly lethal, as is the case in cerebral malaria, 
meningitis and encephalitis [1, 7, 19, 22]. Early diagnosis and adequate treatment can prevent death in many 
of these cases. On the other hand many neurological illnesses are chronic, such as epilepsy, and represent a 
huge socioeconomic burden to the patients and their families [8-10, 15]. Early and adequate treatment may 
prevent chronicity or secondary damage and increase the patients’ and their families’ quality of life. The 
present study supports our previous experience that neurological disorders are frequent in developing 
countries. Of all 8676 admissions 8.5% were due to neurological disorders. Other African studies showed 
similar results. Osuntokun (1971) analysed neurological illnesses from 1957 - 1969 at the University College 
Hospital, Ibadan, Nigeria and calculated a minimum prevalence of neurological diseases in the hospital 
population of 4.2%, not including patients with acute head injury, traumatic paraplegia and febrile convulsions 
[13]. Schmutzhard and Aichner (1982) found that 10% of all patients attending the Voluntary Agency Hospital 
in Mnero, southern Tanzania, suffered from neurological diseases [18]. Another study from Tanzania, Dar es 
Salaam, conducted at the Muhimbili Medical Centre by Matuja and Makene (1989) showed that over a period 
of 12 months 13% of newly admitted patients had neurological diseases [12]. A retrospective study from 
Kwasa (1992) carried out in Kenya showed that neurological disorders made up for 7.5% of all medical 
conditions at the Kenyatta National Hospital [11].
In a Zambian hospital, Birbeck (2001) observed that 10% (186 patients) of the 1886 hospital admissions 
during a 13-week period were due to neurological diseases [2]. Interestingly, a recent study from two hospital 
sites in Ethiopia showed much higher hospital-based prevalences of 18% and 24.7%. Patients’ data were 
collected retrospectively, which may account for the difference in prevalence rates compared to the above 
studies [4]. Bearing in mind that in most studies in developing countries 10% of hospital admissions can be 
attributed to neurological disorders, a huge gap in terms of neurological care becomes evident when looking 
at the actual neurological services in African nations. Thirty-five of the 53 African nations have only few 
neurologists (1-4) or none at all [3]. Thus training of more neurologists who are familiar with the demands of 
resource poor settings seems to be crucial for the future health care of African countries. Also, teaching 
neurology in courses for clinical officers and medical assistants should become part of the curriculum. In our 
study, we found that neurological disorders not only contribute substantially to hospital morbidity but also to 
hospital mortality. 20% of all patients with a neurological diagnosis died in hospital. This compares to 21.8% 
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in a study on neurological diseases in Addis Ababa [4]. The average hospital stay was three weeks and 
patients paid on average 37 220 Tanzanian Shilling, which approximately amounts to US $ 37. This is more 
than what an average Tanzanian family earns in one month (income per capita: US $ 340 in 2005). This fact 
clearly emphasizes the socioeconomic burden of neurological disease with long hospital stay and huge 
financial expenses for the families. In the worst scenario, patients may remain disabled and depend on carers 
which, without social security, represents an additional burden for the already poverty stricken families. Thus, 
early recognition and early as well as effective treatment of neurological disease is of paramount importance.
Diagnosing neurological disease in resource poor settings Based on our working experience of many years 
within African neurological services, we have identified three major diagnostic groups according to the degree 
of diagnostic uncertainty (definitions see diagnostic criteria). Reassuringly, many patients (46%) could be 
diagnosed on clinical grounds alone or with the help of simple diagnostic tools, be it laboratory tests or x-ray 
examination. This is in accordance with findings from Addis Ababa where 42.9% of cases could be 
diagnosed with high certainty [4]. In 43% and 11% of our 740 patients minor and major diagnostic 
uncertainties remained, respectively. However, patients could be categorized according to syndromes, both 
known and unknown. If the clinical symptomatology was unknown a tentative syndromic description has been 
suggested, grouping together cases that clinically were similar.
Classifying neurological diseases in rural Africa is important in terms of diagnostic approach as well as 
therapy and prognosis. Diagnoses belonging to group 1 are important to recognize as early as possible in the 
disease process as often there are crucial therapeutic implications. It is of paramount importance that 
standard treatment regimes, often World Health Organization based, are adhered to. In the case of cerebral 
malaria and meningitis, there are clear diagnostic criteria [1, 22]. In most rural African hospitals, blood slide 
for malaria parasites are being performed and the core features of CSF can be analyzed. Recognition of 
diseases belonging to group 1 ideally leads to immediate life-saving treatment.
If diagnostic uncertainties remain such as in group 2, clinical skills are indispensable in order to make the 
right decision for further investigation and treatment. Referral to a tertiary medical centre may be necessary. 
The third diagnostic category (group 3) is that of “descriptive syndromic grouping”. Patients are summarized 
according to their most prominent symptoms/signs. These patients do not meet the criteria for any known 
neurological disorder, the diagnosis remains “obscure”. Serology (such as HIV) and/or imaging may give a 
clue, but in most rural African hospitals these are not at hand. In previous studies, these patients were 
classified as “miscellaneous” [13], and usually are not elaborated on any further, or they were excluded from 
analysis in the first place, underestimating the overall prevalence of neurological disease. In the age of sub-
Saharan HIV epidemics, some of the patients of group 3, especially those with “obscure encephalopathies” 
may be assumed to suffer from HIV/AIDS related involvement of the central nervous system. When HIV 
testing became available, the area our study was conducted in was however identified as a low prevalence 
setting with prevalence of HIV in the general population of 1.8% [23]. Patients classifying for group 3 as a rule 
have a poor outcome with an on average 30% mortality in hospital. In our opinion, the only appropriate 
approach to these patients is early referral to tertiary health centres where proper medical work up and 
directed therapeutic approach is possible.
In summary, our study shows that neurological disorders are prevalent within a hospital population of rural 
Tanzania. Neurological disease is associated with high mortality, prolonged hospital stay and socioeconomic 
burden for the families. In our study, emphasis is put on a systematic approach suitable for a resource poor 
setting by grouping neurological disorders according to their diagnostic certainties.
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Table 1: Demographic details of patients with neurological disorders
No. of cases 740 
Hospital-based prevalence per 1000 85.29 
Age (years) 
Mean (SD) 26.4 (24.2) 
Median 22.0 
Range 1 day - 100 
Gender 
Male 422 (57%) 
Female 318 (43%) 
Male/female ratio 1.3:1 
Tribes 
Cushitic tribe 439 (59%) 
Bantu tribes 183 (25%) 
Nilotic tribe 76 (10%) 
Unknown 42 (6%) 
Hospital stay (days) 
Mean (SD) 21.6 (34.6) 
Median 8.0 
Range 0 - 249 
Total costs (TSH) 
Mean (SD) 33 135 (36 975) 
Median 20 950 
Range 500 - 36 1500 
Outcome 
Discharged 544 (74%) 
Death 157 (21%) 
Unknown 39 (5%) 
SD: standard deviation, TSH:Tanzanian Shilling 
1000 TSH = 1 US - Dollar (at the time of the study)
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Table 2: Group 1: neurological disorders without diagnostic uncertainties
Case numbers % within the diagnostic group Hospital based prevalence 
Febrile convulsions 83 24.4 9.57 
Meningitis 74 21.8 8.53 
Epilepsy 65 19.1 7.49 
Cerebral malaria 50 14.7 5.76 
Pott’s disease 22 6.5 2.54 
Spina bifida 14 4.1 1.61 
Hydrocephalus 12 3.5 1.38 
Rabies 8 2.4 0.92 
Peripheral nerve injury 5 1.5 0.58 
Bell’s palsy 5 1.5 0.58 
Tetanus 2 0.6 0.23 
Total 340 100 39.18 
Table 3: Group 2: neurological disorders with minor diagnostic uncertainties
Case 
numbers 




Myelo-/radiculo-/plexo-/polyneuropathy 61 19.2 7.03 
Head trauma with neurological 
impairment 55 17.3 6.33 
Seizures other than epilepsy and febrile 
convulsions 49 15.4 5.65 
Non-infectious encephalopathies 43 13.5 4.96 
Cerebrovascular accident 33 10.4 3.80 
Degenerative diseases 21 6.6 2.42 
Dementia/mental retardation 19 6.0 2.19 
Paroxysmal events 17 5.4 1.96 
Space-occupying lesion 13 4.1 1.50 
Myopathies 7 2.2 0.81 
Total 318 100 36.65 
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Table 4: Group 3: neurological disorders with major diagnostic uncertainties
Case numbers % within the diagnostic group Hospital based prevalence 
Acute confusional state 40 48.8 4.61 
Impairment of consciousness 26 31.7 2.99 
Obscure encephalopathy 16 19.5 1.84 
Total 82 100 9.45 
Table 5: Demographic details of patients with major diagnostic uncertainties







Mean (SD) 42.8 (27.1) 34.2 (23.6) 28.5 (22.6) 
Median 35.0 29.0 29.5 
Range 4 - 97 0.5 - 75 0.5 - 80 
Gender 
Male 17 (42.5%) 16 (62%) 10 (62.5%) 
Female 23 (57.5%) 10 (38%) 6 (37.5%) 
Male/female ratio 0.7:1 1.6:1 1.7:1 
Tribes 
Cushitic tribe 26 (65%) 12 (46%) 11 (69%) 
Nilotic tribe 3 (7.5%) 6 (23%) 3 (19%) 
Bantu tribes 6 (15%) 6 (23%) 1 (6%) 
Unknown 5 (12.5%) 2 (8%) 1 (6%) 
Hospital stay 
(days) 
Mean (SD) 15.3 (21.9) 6.7 (9.2) 61.1 (50.5) 
Median 7.5 3.0 51.0 
Days (Range) 1 - 121 0 - 37 2 - 146 
Total costs (TSH) 
Mean (SD) 34 717 (25 561) 32 980 (36 903) 65 816 (51 031) 
Median 30 000 24 090 52 500 
Range 3000 - 103 400 1400 - 160 000 6700 - 180 500 
Outcome 
Discharged 33 (82.5%) 15 (58%) 9 (56%) 
Death 7 (17.5%) 11 (42%) 5 (31%) 
Unknown - - 2 (13%) 
SD: standard deviation, TSH:Tanzanian Shilling 
1000 TSH = 1 US - Dollar (at the time of the study)
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